BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16042419)

  • 1. Factor XIa dimer in the activation of factor IX.
    Sinha D; Marcinkiewicz M; Lear JD; Walsh PN
    Biochemistry; 2005 Aug; 44(30):10416-22. PubMed ID: 16042419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential.
    Gailani D; Ho D; Sun MF; Cheng Q; Walsh PN
    Blood; 2001 May; 97(10):3117-22. PubMed ID: 11342438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.
    Wu W; Sinha D; Shikov S; Yip CK; Walz T; Billings PC; Lear JD; Walsh PN
    J Biol Chem; 2008 Jul; 283(27):18655-64. PubMed ID: 18441012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI apple domains and protein dimerization.
    Cheng Q; Sun MF; Kravtsov DV; Aktimur A; Gailani D
    J Thromb Haemost; 2003 Nov; 1(11):2340-7. PubMed ID: 14629467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.
    Smith SB; Verhamme IM; Sun MF; Bock PE; Gailani D
    J Biol Chem; 2008 Mar; 283(11):6696-705. PubMed ID: 18192270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of coagulation factor XI by a casein kinase released by activated human platelets increases its susceptibility to activation by factor XIIa and thrombin.
    Ekdahl KN; Elgue G; Nilsson B
    Thromb Haemost; 1999 Oct; 82(4):1283-8. PubMed ID: 10544914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
    Baglia FA; Walsh PN
    J Biol Chem; 2000 Jul; 275(27):20514-9. PubMed ID: 10781579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modification of factor XIa functional activity upon binding to polyanions.
    Sinha D; Badellino KO; Marcinkiewicz M; Walsh PN
    Biochemistry; 2004 Jun; 43(23):7593-600. PubMed ID: 15182201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a factor IX binding site on the third apple domain of activated factor XI.
    Sun Y; Gailani D
    J Biol Chem; 1996 Nov; 271(46):29023-8. PubMed ID: 8910554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of factor XI and some properties of activated factor XI from porcine plasma.
    Mashiko H; Takahashi H
    Agents Actions Suppl; 1992; 38 ( Pt 2)():249-56. PubMed ID: 1462831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate-dependent modulation of the mechanism of factor XIa inhibition.
    Pedicord DL; Seiffert D; Blat Y
    Biochemistry; 2004 Sep; 43(37):11883-8. PubMed ID: 15362874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.
    Miller TN; Sinha D; Baird TR; Walsh PN
    Biochemistry; 2007 Dec; 46(50):14450-60. PubMed ID: 18020374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism underlying activation of factor IX by factor XIa.
    Gailani D; Geng Y; Verhamme I; Sun MF; Bajaj SP; Messer A; Emsley J
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S48-51. PubMed ID: 24759143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa.
    Geng Y; Verhamme IM; Sun MF; Bajaj SP; Emsley J; Gailani D
    J Thromb Haemost; 2013 Jul; 11(7):1374-84. PubMed ID: 23617568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of factor IX by factor XIa--a spectrophotometric assay for factor IX in human plasma.
    Tans G; Janssen-Claessen T; van Dieijen G; Hemker HC; Rosing J
    Thromb Haemost; 1982 Oct; 48(2):127-32. PubMed ID: 6983739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
    Bozzao C; Rimoldi V; Asselta R; Landau M; Ghiotto R; Tenchini ML; De Cristofaro R; Castaman G; Duga S
    FEBS J; 2007 Dec; 274(23):6128-38. PubMed ID: 17971173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation.
    Sinha D; Marcinkiewicz M; Navaneetham D; Walsh PN
    Biochemistry; 2007 Aug; 46(34):9830-9. PubMed ID: 17676929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apple four in human blood coagulation factor XI mediates dimer formation.
    Meijers JC; Mulvihill ER; Davie EW; Chung DW
    Biochemistry; 1992 May; 31(19):4680-4. PubMed ID: 1581318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa.
    Bar Barroeta A; van Galen J; Stroo I; Marquart JA; Meijer AB; Meijers JCM
    J Thromb Haemost; 2019 Dec; 17(12):2047-2055. PubMed ID: 31519061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.
    Sun MF; Zhao M; Gailani D
    J Biol Chem; 1999 Dec; 274(51):36373-8. PubMed ID: 10593931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.